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3ABSTRACT
Although numerous germ-cell mutagens have been identified in animal model systems, to
date, no human germ-cell mutagens have been confirmed.  Because the genomic integrity of our
germ cells is essential for the continuation of the human species, a resolution of this enduring
conundrum is needed.  To facilitate such a resolution, we organized a workshop at The Jackson
Laboratory in Bar Harbor, Maine on September 28-30, 2004.  This interactive workshop brought
together scientists from a wide range of disciplines to assess the applicability of emerging
molecular methods for genomic analysis to the field of human germ-cell mutagenesis.
Participants recommended that focused, coordinated human germ-cell mutation studies be
conducted in relation to important societal exposures.  Because cancer survivors represent a
unique cohort with well-defined exposures, there was a consensus that studies should be
designed to assess the mutational impact on children born to parents who had received certain
types of mutagenic cancer chemotherapy prior to conceiving their children.  Within this high-risk
cohort, parents and children could be evaluated for inherited changes in (a) gene sequences and
chromosomal structure, (b) repeat sequences and minisatellite regions, and (c) global gene
expression and chromatin.  Participants also recommended studies to examine trans-generational
effects in humans involving mechanisms such as changes in imprinting and methylation patterns,
expansion of nucleotide repeats, or induction of mitochondrial DNA mutations.   Workshop
participants advocated establishment of a bio-bank of human tissue samples that could be used to
conduct a multiple-endpoint, comprehensive, and collaborative effort to detect exposure-induced
heritable alterations in the human genome.  Appropriate animal models of human germ-cell
mutagenesis should be used in parallel with human studies to provide insights into the
mechanisms of mammalian germ-cell mutagenesis.  Finally, participants recommended that
4scientific specialty groups be convened to address specific questions regarding the potential
germ-cell mutagenicity of environmental, occupational, and lifestyle exposures.  Strong support
from relevant funding agencies and engagement of scientists outside the fields of genomics and
germ-cell mutagenesis will be required to launch a full-scale assault on some of the most
pressing and enduring questions in environmental mutagenesis:  Do human germ-cell mutagens
exist, what risk do they pose to future generations, and are some parents at higher risk than
others for acquiring and transmitting germ-cell mutations?
5INTRODUCTION
Because the future of the human species resides in our germ cells (egg and sperm), it is
vitally important that we determine if environmental factors are adversely impacting the genomic
integrity of our germ cells.  There is a wealth of data on mutation induction in somatic cells of
rodents and humans; however, these data cannot be used to assess mutational risk of human germ
cells due to the unique biological characteristics of human germ cells relative to those of other
mammals or to somatic cells of either humans or other mammals.  Thus, to accurately assess the
impact of environmental mutagens on the genomic integrity of human germ cells, studies must
be conducted directly in human populations.
Starting 80 years ago with Herman Muller’s discovery in 1927 of the first germ-cell
mutagen (ionizing radiation) in an animal (Drosophila), studies in various animal model systems
have shown that certain physical and chemical mutagens can induce heritable mutations, i.e.,
mutations in the germ cells that are transmitted to offspring.  However, despite the similarities in
many aspects of germ cell biology among humans and mammalian model systems, studies
during the past 80 years have failed to find clear and convincing evidence of environmentally
induced heritable mutations in humans.
Beyond the unlikely possibility that there are no human germ-cell mutagens, the reasons
for this disparity between human and animal studies are many:  insufficient numbers of human
subjects; insensitive methods to detect mutations; the multiplicity of DNA and chromosomal
defects induced by individual mutagens; inadequate length, intensity, or type of exposure; and
inadequate dosimetry.  Nonetheless, to date, there are still no confirmed, universally agreed-upon
mutagens that produce transmissible human germ-cell mutations—not one.
6However, recent advances in genomic biology and biotechnology now offer the
unprecedented opportunity to apply new technologies and molecular methods to the critically
important questions regarding the existence of human germ-cell mutagens and the heritable risks
they might pose for the next generation.  With this in mind, we organized a workshop titled
“Assessing Human Germ-Cell Mutagenesis in the Post-Genome Era” at The Jackson Laboratory
in Bar Harbor, Maine on September 28-30, 2004.  Our intent was to foster a dialogue among
scientists in the fields of germ-cell mutagenesis and genomics, with the goal of encouraging
collaborative efforts to detect human germ-cell mutagens.  While planning this conference, one
of the pioneers in the field of mammalian germ cell mutagenesis, Dr. William B. Russell, died.
We dedicated this workshop to his memory and legacy of research in this field.
The workshop was attended by 98 scientists, and their presentations and discussions
reviewed the special biology of germ cells as well as the epidemiological and sperm-based
evidence for environmentally induced de novo human germ-cell mutations.  Participants also
provided an update and evaluation of the new genomic technologies available for measuring
random DNA sequence mutations, chromosomal alterations, and changes in gene expression
across the human genome.  Participants made suggestions for research strategies and technical
developments that could aid in addressing the existence of and risk associated with exposure to
human germ-cell mutagens.
We anticipate that the topics and issues discussed in this workshop report will help to
spark more intense collaborations among scientists in the fields of genomics and germ-cell
mutagenesis.  We trust that the urgency for such collaborative efforts will be recognized by
scientists and funding agencies alike, such that we will not have to wait another 80 years to
answer the questions:  Are there any human germ-cell mutagens, what risks do they pose to
7future generations, and are some parents more susceptible than others for acquiring and
transmitting germ-cell mutations?
8KEYNOTE ADDRESS
Liane B. Russell, Oak Ridge National Laboratory
In the opening address, Liane Russell gave an overview of the pioneering work of her late
husband, Bill Russell.  Bill Russell held an early fascination with phenotypic variation within
inbred strains of mice, which led to his development of the technique of ovarian transplantation
(from inbreds into their F1 hybrids) to study the influence of the prenatal environment on
phenotypic variability among genetically uniform mice.  He then developed the mouse specific-
locus test, which allowed quick and objective detection of visible recessive mutations among any
of seven loci.  Russell utilized the specific-locus test to study the effects of different qualities of
radiation, total dose, dose protraction, and dose fractionation.  His results with dose protraction
provided early evidence that certain germ cells could repair pre-mutational damage.  Russell and
coworkers explored the roles of sex, parity, age, and (most importantly) germ-cell stage on
mutation rate and type.  Later in his career, Russell pioneered the application of the specific-
locus test to study the induction of germ-cell mutations by chemicals.  These studies led to what
is perhaps the most important legacy of his work in germ-cell mutagenesis—his discovery that
ethylnitrosourea (ENU) is a potent germ-cell mutagen in the mouse.  ENU is still used
extensively in a wide variety of mutagenesis studies because of its propensity for generating
point mutations and not insertions/deletions or chromosomal rearrangements.
Key discoveries by the Russells regarding the nature of mutations detected in mouse
spermatogonial cells following specific chemical or radiation exposures revealed that each
chemical had its own characteristic germ-cell stage-sensitivity pattern, and all chemicals, as well
as radiations, produced primarily large lesions, e.g., deletions and inversions, in post-
spermatogonial stages but not in pre-meiotic or meiotic stages.  Furthermore, the Russells
9discovered that the locus-spectra of spontaneous mutations identified in mouse sperm, many of
which were shown to originate during the perigametic interval, differed from the ENU-induced
spectra.
Liane Russell concluded with a discussion of future prospects in germ-cell mutagenesis
research.  She expressed the hope that new high-throughput, genomics-based molecular tools
would lead to rapid progress in understanding unresolved questions about germ-cell biology and
mutagenesis in mice and in humans, thereby enhancing the approaches used for the estimation of
germ-cell risk.
SESSION 1:  HISTORICAL PERSPECTIVES AND IMPACT OF GENOME PROJECT
Session Chair:  John S. Wassom, Oak Ridge National Laboratory
John S. Wassom posed one of the central questions in the field of germ-cell mutagenesis:
"Do environmental agents induce heritable mutations in humans?" and summarized published
and unpublished evidence from 1960 to the present.  The lack of a definitive answer to this
question was a significant motivation for this workshop.  He echoed Liane Russell in
emphasizing the need for developing new strategies employing recently developed genomic
biotechnologies to identify and characterize environmental agents that have the potential of
inducing heritable mutations in humans.
The Human Perspective
John J. Mulvihill, University of Oklahoma Health Sciences Center
John J. Mulvihill described heritable mutagenesis as a process that has both a background
component that is inherent to the individual and an induced component that results from
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environmental exposures.  He argued that an as-yet-undefined fraction of hereditary human disease
is attributable to the latter.  He acknowledged the lack of definitive evidence for environmentally
induced germ-cell mutations in humans, and he proposed that cohort studies that monitor sentinel
phenotypes and other endpoints would be more advantageous than case-control studies to
understand human germ-cell mutagenesis and its role in human disease.  Sentinel phenotypes result
from highly penetrant mutations in dominant (or X-linked) genes, and they have a high mutational
component.  Alternatively, molecular methods could be used to identify genomic mutations in
exposed human populations.  Molecular approaches are currently available in animal models that
allow for direct measurement of aneuploidy, chromosome aberrations, inversions, deletions, copy
number changes, and point mutations; some of these are immediately applicable for human studies.
Mulvihill described two available cohorts and their advantages for future molecular studies:
(1) atomic bomb survivors and their offspring and (2) cancer survivors and their offspring.  To date,
no evidence of a statistically significant increase in adverse pregnancy outcomes has been observed
in the offspring of atomic bomb survivors.  Studies of cancer survivors are ongoing.  Cancer
survivors are particularly advantageous because they are numerous and, most importantly, because
the timing and dose of their exposure to radiation and/or mutagenic chemicals is accurately
documented.  Initial studies of the frequency of birth defects in offspring of cancer survivors have
shown no significant differences from the average frequency in the US population.  These data
suggest that the agents and doses to which these individuals have been exposed do not induce
transmissible mutations in human spermatogonial stem cells and resting oocytes at a frequency high
enough to be detected over the background of spontaneous mutations, but larger studies are needed.
History of Germ-Cell Mutagenesis
11
R. Julian Preston, US Environmental Protection Agency
R. Julian Preston reviewed the history of research on germ-cell mutagenesis and the current
paradigm for human risk assessment.  Early data on germ-cell mutagenesis generated in mouse
specific-locus tests conducted in the 1950s and 1960s demonstrated the impact of fundamental
aspects of germ-cell biology on germ-cell mutagenesis.  These studies established that dose, dose-
rate, sex, germ-cell stage and radiation quality influence experimental outcomes, and the results
were species-specific and difficult to extrapolate in a quantitative manner from one species to
another.  Preston emphasized the role of germ-cell stage in determining specific sensitivities for
various mutagenic outcomes.  Because the exact timing of germ-cell maturation is in itself species-
specific, the relative sensitivity of the germ cells to radiation at different life cycle stages varies
significantly from one species to another and, therefore, must be determined empirically.
One approach to the identification of germ-cell mutagens is by direct analysis of
chromosome aberrations in human and animal sperm.  Studies of sperm samples from cancer
patients who received radiation and/or chemotherapy were analyzed and showed that sperm-cell
stage, the time of exposure, and the dose of radiation all influence the frequency of aneuploidy
and/or chromosome aberrations in the sperm that are subsequently produced.  In general, there are
significantly fewer data on chemically induced compared to radiation-induced germ-cell
mutagenesis in both humans and experimental animals.
Recent studies have reported increased minisatellite instability in human and animal germ
cells exposed to ionizing radiation.  The significance of these data is not yet clear, and more studies
are needed to assess their implication for human risk assessment.  Finally, Preston emphasized that
more studies are needed to determine which environmental exposures increase the frequency of
germ-cell mutations in human populations.  He also emphasized that the effects of radiation or
12
chemical exposure are likely to depend on the interaction between DNA replication and DNA
repair pathways in germ cells.  Because the mechanisms underlying these processes vary during
gametogenesis, germ-cell stage is a critical determinant of the effects of exposure on the frequency
of offspring with heritable defects.
How Genome Sequence Impacts Germ-Cell Mutation and Health
Robert K. Moyzis, University of California, Irvine
Robert K. Moyzis gave a historical overview of the landmark Human Genome Project
(HGP) and its relationship to the field of human germ-cell mutagenesis.  Referring to
deliberations at the 1984 Alta Conference, the 1986 Sante Fe meeting, and the 1988 Cold Spring
Harbor meeting, Moyzis explained that the HGP initially arose out of concern for the potential
impact of environmental mutagens on the integrity of the human genome.  However, with time,
the HGP changed its focus to concentrate on large-scale comparative genomics and DNA
sequencing technology, the development of model organisms for genomics studies, and the
ethical implications of human genomics research.
Although there is one organizational structure of the human genome, there are ~6 billion
unique sequence variations of this genome.  This diversity among individuals contributes to
differences in susceptibility to disease.  The completion of the human genome map has led to
rapid progress in understanding the DNA sequence changes underlying rare, single-gene
Mendelian disorders.  Common polygenic diseases have presented a greater challenge, but
technological advances now enable scientists to use a pathway approach to study such diseases.
Moyzis illustrated the pathway approach using attention deficit hyperactivity disorder (ADHD).
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Because this behavioral syndrome involves altered neurological function, Moyzis selected a
handful of genes that encode neurotransmitter receptors to screen for disease-associated variants.
He discovered that one of the three most common alleles of dopamine receptor D4 (DRD4), the
7R allele, is enriched ~2-fold in individuals with ADHD.  This allele carries a 7-mer VNTR
(variable number of tandem repeats) in exon 3, unlike the most common variant, which has a 4-
mer VNTR repeat, or the third most common variant, which has a dimer VNTR repeat.  The 7R
allele is not distributed randomly worldwide, being more common in individuals from North and
South America.   Haplotype analysis of the 7R and other alleles showed uncommonly high
linkage disequilibrium for the 7R allele.  This led Moyzis to propose that the 7R allele arose
relatively recently in evolutionary history (50,000 years ago) and was driven to high population
frequency by positive selection.  The association of 7R with ADHD may reflect its interaction
with genetic or environmental factors that were absent when the allele became prevalent in the
population.  Moyzis suggested that further study of variants of the human genome will yield
significant insight into the evolutionary history of humans and the environmental forces that may
cause germ-cell mutation.
SESSION 2:  GERM-CELL BIOLOGY AND MUTAGENESIS
Session Co-Chairs:  Susan E. Lewis, Consultant; John B. Mailhes, LSU Health Sciences
Center
Germ-Cell Biology:  Animal Models versus Human, Male versus Female
Mary Ann Handel, Jackson Laboratory
Mechanisms of Germ-Cell Stage Susceptibilities
Jack B. Bishop, National Institute of Environmental Health Sciences
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Mary Ann Handel and Jack B. Bishop presented broad overviews of germ-cell biology
and its relevance to the susceptibility of germ cells to environmental mutagens.  Common themes
discussed in both talks were sexual dimorphism and the unique characteristics and
susceptibilities of distinct germ-cell stages.  The time line for the production and maturation of
germ cells is dramatically different in female and male mammals.  For all mammals, female
germ cells complete meiotic prophase I during fetal growth and remain arrested in diplotene until
the onset of puberty.  In contrast, male germ cells undergo mitosis prior to birth but do not
undergo a meiotic division until puberty.  In human females, all germline mitotic divisions are
completed within days during embryonic development; completion of meiosis I requires years
and does not begin until puberty; and completion of meiosis II occurs within hours after
fertilization.  There is limited mitotic proliferation in females, and the number of female germ
cells is limited.  In human males, mitotic proliferation begins near the time of puberty and
continues throughout life well into senescence.  Spermatogonial stem cells undergo asymmetric
division, generating a stem cell and germ cells that undergo numerous mitotic divisions over
several weeks, followed by two meiotic divisions that occur with a few hours of each other.
Handel emphasized the sex-specificity of checkpoints during germ-cell maturation and
Bishop emphasized the sex- and stage-specificity of DNA repair capacity.  The relative
competence of the various germ-cell stages, both for checkpoint control of the cell cycle and for
DNA repair, has a clear impact on the ability of environmental agents to induce mutations in the
various germ-cell stages.  Male germ cells appear to have a more efficient meiotic checkpoint
than female germ cells; however, male germ cells are DNA repair-deficient in post-meiotic
stages, while post-meiotic female germ cells retain the capacity for DNA repair.  Bishop stressed
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the importance of being aware of which germ cell stage(s) are exposed and which are sampled
when designing experiments to assess the impact of environmental agents on germ cells.
Handel reported on a large-scale joint initiative between investigators at the Jackson
Laboratory and Cornell University to identify genes required for meiosis and fertility in mice.
Mice with meiotic gene mutations were generated by treating males with ENU.  The progeny of
G2 backcrosses were then screened for infertility.  Approximately 11,000 mice have been tested
for fertility defects to date.  Thirty-six mutations have been identified: 25 of these resulted in
male infertility, 8 caused infertility in both sexes, and 3 resulted in female infertility.  This sex
bias might indicate a higher level of complexity in male gametogenesis than in female
gametogenesis, or it could suggest greater pleiotropy in the action of genes required for female
reproduction.  Molecular studies indicate that many of these mutants have defects that affect
either mitotic proliferation of primordial germ cells or meiotic mechanisms of chromatid
cohesion and recombination.  Future studies will include testing the epistatic relationship of these
mutants to mice with previously characterized defects in meiosis.  Additional information about
this project can be found at http://reprogenomics.jax.org/.
Egg Repair of DNA Damage
Francesco Marchetti, Lawrence Berkeley Laboratory
     Francesco Marchetti discussed DNA repair capacity and mechanisms in mammalian germ
cells and during the early stages of embryogenesis.  DNA repair capacity varies with
developmental stage; thus, the relative timing of the induction of DNA damage, DNA
replication, and DNA repair strongly influence the potential impact of DNA damage on germ-
cell and embryo viability.
16
     Oocytes have a high DNA repair capacity, and they retain maternal protein and mRNA,
including abundant DNA repair proteins and transcripts encoding DNA repair proteins.
However, the protein and mRNA complement, as well as the transcriptional profile of the
fertilized oocyte, changes significantly during the earliest mitotic divisions (through the 4-cell
stage); zygotic transcription is initiated near the beginning of the 2-cell stage.  Thus, there is a
narrow window of time in which sperm DNA damage can be repaired in the early embryo.  This
is particularly important for the male genome, which has not undergone DNA repair for several
weeks prior to fertilization.  Experimental evidence shows that the maternal genotype affects the
efficiency with which oocyte enzymes can repair DNA damage in the paternal genome,
suggesting that the repair capacity of oocytes may vary across individuals of different genetic
backgrounds.
     Marchetti examined the role of specific DNA repair pathways in repairing radiation-
induced DNA lesions during early embryogenesis by mating irradiated male mice with un-
irradiated female mice that were deficient for genes involved in homologous recombination-
dependent double-strand DNA break repair (HR-DSBR) or non-homologous end-joining (NHEJ)
repair.  His experiments revealed that both pathways are active in the early mouse embryo and
play important roles in preventing the formation of chromatid-type and chromosome-type
aberrations resulting from DNA damage in the fertilizing sperm.  Similar experiments were
conducted to demonstrate that a p53-dependent S-phase checkpoint is active during early mouse
embryogenesis.  In conclusion, the available evidence from mouse studies demonstrates the
existence of maternal factors that result in differential conversion of sperm DNA lesions into
paternally transmitted chromosome damage, and suggest that quantitative and qualitative
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limitations in maternal DNA repair can have profound effects on modifying the risks for
abnormal reproductive outcomes of paternal origin.
Mosaicism and Germ-Cell Mutagenesis
Harvey W. Mohrenweiser, Oregon Health Sciences University
Harvey W. Mohrenweiser discussed the potential impact of mosaicism (genetic
heterogeneity caused by mutations that arise after fertilization during embryogenesis) on
phenotypic and genotypic variation in mammals.  Some mosaicism is the result of normal
biological processes, including genomic imprinting, X-inactivation, and DNA methylation.
Some aberrant processes can be associated with pathological conditions or environmental
exposures.  For example, mutations that occur during embryogenesis can be spontaneous or can
result from exposure to mutagens; they may also arise from chromosome aberrations occurring
during mitotic cell divisions.  The fraction of embryonic tissue affected by such mutations
depends on the stochastic distribution of cells during embryonic development.  The greater the
fraction is of affected cells, the greater the potential for an adverse outcome.
Mohrenweiser estimated that as many as 10-20% of mutations in a given gene can be
attributed to events occurring during early embryogenesis; the remaining 80% of new mutations
are inherited from the parental germline or arise postnatally.  When more than one offspring of
the same parent is affected by the same disease, and neither parent carries the mutant allele in
their somatic cells, then the parent is likely to have germline mosaicism. Germline mosaicism is
not uncommon, but the frequency is gene-specific and varies dramatically across different
regions of the human genome.  Recent studies indicate that mosaicism occurs at a high frequency
in human embryos produced in vitro using assisted reproductive technology (ART).  For
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example, ~75% of ART embryos on day 2 show mosaicism and 100% of ART embryos in more
advanced stages have some mosaic character.  These frequencies likely reflect the abnormal
conditions in which ART embryos are formed and manipulated.  However, they suggest that the
rate and potential impact of mosaicism under biologically relevant conditions may be
underestimated; somatic and germline mosaicism could make a significant contribution to
sporadic and inherited genetic disease.
Sessions 3/4: New Approaches for Detecting Heritable Mutations
Session Chairs:  David M. DeMarini, US Environmental Protection Agency; Carole L.
Yauk, Health Canada
Single-Sperm PCR Genotyping
Norman Arnheim, University of Southern California
Detecting Chromatin, DNA and Chromosomal Abnormalities in Sperm
Andrew J. Wyrobek, Lawrence Berkeley Laboratory
Norman Arnheim and Andrew J. Wyrobek described recent advances in molecular
detection of gene mutations, DNA damage, and chromosome defects in human sperm.  A major
advantage of analyzing sperm directly versus groups of offspring is that a much larger number of
gametes per individual can be assessed for genomic defects compared with the small numbers of
affected offspring typically available for epidemiological studies of male-mediated effects.  The
statistical advantage of sperm studies was illustrated by estimating the number of families with
offspring that would need to be screened to detect a doubling of affected offspring after a
hypothetical parental exposure: ~900 families for birth defects, ~300 for spontaneous abortions,
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and ~250,000 for childhood leukemia.   In contrast, sperm studies usually require £10 men per
group to detect ~2-fold effects, depending on the specific assay used.  The main limitation of
sperm assays is that they are restricted to paternal exposures.  In addition, more research will be
needed to elucidate the cellular and biochemical events that occur after sperm release that may
modify the probability of a genetically defective sperm producing a child with a heritable defect
of paternal origin, such as the role of selection pressures for or against defective sperm during
fertilization, maternal DNA repair of sperm DNA lesions in the zygote, and epigenetic
modifications of sperm DNA.  Nevertheless, sperm assays are a promising approach for
screening for potentially hazardous compounds and prioritizing medical, occupational, and
lifestyle factors that may induce heritable disease due to gene mutations and chromosomal
alterations in male germ cells.
Arnheim described several PCR- and direct sequencing-based assays that measure mutant
frequency at a specific nucleotide in the fibroblast growth factor receptor genes FGFR2 or
FGFR3, which are associated with dominantly inherited Apert syndrome and achondroplasia,
respectively.  The two specific nucleotides have a mutation frequency that is much higher than
the average, and mutations in these two genes occur predominantly in the paternal genome at the
same nucleotide.  Quantitative, allele-specific PCR is used in these assays to amplify specific
mutant alleles with a sensitivity of approximately 10-5.  To use this method successfully to detect
Apert syndrome mutations, a DNA sample of ~5 µg is required; however, to detect a more
typical mutation at 10-8, ~5 mg of DNA would be needed, which is not feasible in all cases.  To
improve the current sensitivity and specificity of single-base mutation detection methods,
Arnheim developed a modified assay that uses a dideoxy-blocked, mutant-specific
oligonucleotide as the PCR primer.  Using a DNA polymerase that carries out
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pyrophosphorolysis, the primer annealed to mutant DNA becomes unblocked, and the rare
mutant template is preferentially amplified.  The assay background is decreased dramatically,
and the sensitivity of the assay improves by about three orders of magnitude compared to
standard allele-specific PCR.
Arnheim briefly described methods to enhance assay sensitivity and detect low-frequency
mutations in human sperm DNA.  These methods can enrich for a mutant allele, deplete the wild-
type allele, or selectively tag and sort mutant and wild-type alleles, i.e., selective restriction
digestion of the wild-type allele, sequestering the mutant allele via specific binding probes,
followed by PCR with beads-emulsion-amplification-magnetics (BEAMing).
Wyrobek described three molecular techniques for analyzing DNA damage and
cytogenetic defects directly in human sperm:  sperm comet assay, sperm chromatin structure
assay (SCSA), and sperm fluorescence in situ hybridization (FISH).  The sperm comet assay is a
single-cell gel electrophoretic method typically applied to ~100 sperm nuclei per sample to
quantitate single-strand or double-strand DNA breaks.  SCSA is a flow cytometric method that
employs acridine orange to measure the relative proportions of single- and double-stranded DNA
in several thousand sperm.  SCSA results are thought to represent the degree of DNA
fragmentation per specimen and the proportions of sperm with immature (no protamines)
chromatin.
Several human sperm FISH methods have been developed to detect aneuploidy and
structural chromosomal alterations, including breaks as well as partial chromosomal duplications
and deletions.  Multi-color FISH has been applied to detect aneuploidies for multiple
chromosomes in ~10,000 sperm per specimen; DNA probe combinations can detect sperm
associated with increased risks for aneuploidy syndromes including Down, Edwards, Turner,
21
Klinefelter, XXX, and XYY, as well as other autosomal trisomies.  Most of these human sperm
assays have already been adapted for studies in animal models.
Wyrobek summarized studies that have applied sperm FISH technologies to assess the
effects of cancer chemotherapy, occupational exposures, and lifestyle factors on the incidence of
sperm aneuploidy.  He observed a 5-fold variation in baseline frequencies of sperm aneuploidy
among healthy donors; however, he also noted that aneuploidy frequencies may remain stably
elevated for years.  There is also limited evidence that the frequency of aneuploidy in sperm is
correlated with the frequency of aneuploidy in lymphocytes, suggesting that there may be
constitutive mechanisms leading to aneuploidy that affect both germ cells and somatic cells.
Wyrobek summarized the results of a large study of the association between advancing male age
and the levels of physiological and genetic damage in sperm.  Results showed that advancing
male age was strongly associated with detrimental effects on motility, DNA fragmentation,
chromosomal aberrations, DNA damage, and gene mutations in sperm, but not with aneuploidy
frequency.
Wyrobek called for investigations of the predicative values of sperm biomarkers for
abnormal reproductive outcomes, including developmental defects and heritable genetic disease.
Sperm biomarkers of genomic damage would serve to identify medical, occupational, and
environmental exposures as well as human lifestyle factors that may be detrimental to the
integrity of the male germline.  They would also be useful in comparing the relative sensitivities
of human somatic and human germ cells to these kinds of exposures, in assessing the relative
risks of somatic versus heritable diseases, and for linking the rodent model and human data.
Oocyte Microenvironment and Transmitted Chromosomal Abnormalities
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Ursula Eichenlaub-Ritter, University of Bielefeld, Germany
Ursula Eichenlaub-Ritter described studies of the human oocyte genome using FISH,
spectral karyotyping (SKY) and comparative genomic hybridization (CGH).  The majority of
these studies were carried out with unfertilized human oocytes generated by assisted
reproductive technology (ART).  FISH and CGH analyses indicate aneuploidy rates from 20 to
52% in human oocytes.  In contrast, studies using conventional chromosome analysis methods
estimated a lower frequency of 11%.  These differences may be associated with maternal age-
effects.  The extent of total aneuploidy and specific types of chromosome abnormalities strongly
increased with age of the female donor.  Eichenlaub-Ritter proposed that age-related differences
in gene expression during oogenesis are important factors in susceptibility to meiotic error.  For
instance, mouse studies suggest that an age-dependent decrease in the efficiency of the Mad
(Mitotic Arrest Deficiency) 2-dependent cell cycle checkpoint in oocytes can predispose to
induction of aneuploidy in human oocytes.
Eichenlaub-Ritter also described studies of chemically induced errors in chromosome
distribution in mammalian oocytes, using enhanced polarizing microscopy, a non-invasive
technique that reveals changes in spindle formation that predispose to nondisjunction.  This
method can be combined with other more conventional methods to analyze the impact of
hormones, life style, age, or environmental exposure on the frequency of chromosomal
abnormalities in human oocytes that are fertilized by intra-cytoplasmic sperm injection (ICSI) in
assisted reproduction.  Such retrospective or prospective non-invasive methods may help to
identify intrinsic factors detrimental to female fertility, such as a reduced follicle pool, altered
hormonal homeostasis or maternal age, and length of the meiotic arrest, as well as extrinsic
factors like chronic or acute exposures to aneugens in induction of chromosomal aberrations in
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human oocytes and embryos.  Furthermore, an in vitro mouse ovarian follicle culture method
was described for modeling the growth, maturation, and ovulation of oocytes.  This technique
may facilitate the assessment of risk to mammalian oocytes within follicles from acute, sub-
chronic, or chronic exposures to meiotic aneugens.  In addition, this model may aid in the
analysis of direct and indirect mechanisms of aneuploidy induction in oocytes and in
identification of targets of drug action in the somatic compartment or in the germ cell itself.
Eichenlaub-Ritter pointed out that such models might also be useful to detect risks for exposure-
induced epigenetic changes in mammalian oocytes.
Haplotype Analysis and Human Genetic Disease
Jack A. Taylor, National Institute of Environmental Health Sciences
Jack A. Taylor discussed studies of human genetic diversity associated with single
nucleotide polymorphisms (SNPs).  In particular, he described the Environmental Genome
Project (EGP), a systematic human genome resequencing project sponsored by the National
Institute of Environmental Health Sciences.  The goal of the EGP is to assess genetic diversity in
a subset of human genes that are predicted to influence susceptibility to environmentally induced
disease.  Initial studies focused on 100 cell cycle and DNA repair genes.  These genes were
resequenced in 90 ethnically diverse individuals.  Approximately 9000 total SNPs were
identified, including ~2000 SNPs with a frequency ≥5%.  There were on average 20 common
SNPs per gene.  Not all possible combinations of SNPs were observed.  Instead, SNPs associate
with one another into linked groups called haplotypes.  On average, there are 3-4 common
haplotypes per gene.  Many haplotypes are shared across ethnic groups, suggesting that they
arose before human ethnic divergence ~100,000 years ago.  Taylor suggested that a few SNPs,
24
each representing a different haplotype, can be used to examine whether the common variants of
a gene are associated with disease.
New germline mutations occur on the background of an existing haplotype.  Unless there
has been recombination, a rare mutation will continue to persist on the haplotype background on
which it arose.  The common haplotypes of genes may thus also act as a surrogate for the rare
mutation and further aid in the discovery of the genetic variant that increases disease
susceptibility.
Inherited Microdeletions, Translocations, and Rearrangements
Jane Fridlyand, Cancer Research Institute/UCSF Comprehensive Cancer Center
Jane Fridlyand overviewed several methods for conducting whole-genome scans for
genomic alterations, including FISH, SKY, end sequence profiling (ESP) and array-based
cellular genomic hybridization (CGH).  Fridlyand indicated that an ideal method for a whole-
genome scan should be inexpensive and readily automated for high throughput, provide high
resolution and high sensitivity, and be able to detect both balanced and unbalanced DNA
rearrangements, i.e., translocation or copy number changes.  No currently available method
fulfills all of these requirements.  For example, the resolution of SKY is 1 to 10 Mb, making it
unsuitable for detecting gene-dosage alterations.  ESP, on the other hand, can be used to detect
all types of chromosomal alterations, including changes in the number of copies of a gene, but it
is currently too expensive for routine use.  Although chromosome CGH has relatively low
resolution, the resolution of array-based CGH can be high because the sensitivity is determined
by the size and number of hybridization probes on the array.  Current technology allows for
maximal resolution approaching 100 kb using tiled arrays of Bacterial Artificial Chromosome
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(BAC) clones.  BAC arrays providing complete coverage of the human genome are now
becoming available from academic centers.  In addition, commercial manufacturers of
oligonucleotide-based arrays are working to develop these for DNA copy number analysis.
Fridlyand described several experiments in which array CGH was used to analyze gene
dosage for human and mouse genes.  Fridlyand used a 2500-element BAC array with ~1.4 Mb
resolution to analyze DNA samples from human peripheral blood and somatic tissue.  Whole-
genome scans with this array can detect a deletion or amplification involving DNA sequences
within a single BAC array element.  In a study of 44 patients, 22 of whom had a deletion
affecting a single array element, no false positives or negatives were observed.  Fridlyand also
presented array CGH data that identified copy number variation in Kringle repeat elements in the
human apolipoprotein gene and indicated that this is just one example of the frequent “normal”
polymorphisms in the human genome that result in DNA dosage variation.  She also presented
results that showed that changes in copy number detected by the mouse BAC array are specific
to individual inbred strains and that these data can be used to cluster strains of mice and
accurately distinguish among individuals of different strains.  These data suggest that rare
deletions or amplifications can be detected with relatively high accuracy using an array CGH of
appropriate resolution.  However, Fridlyand cautioned that it remains a challenge to differentiate
between technical noise, i.e., false positives or negatives, normal genetic variation, and novel
variants due to copy number events in the target genome.
In summary, Fridlyand indicated that array-based CGH can be used effectively to detect
heritable chromosome aberrations at 50-100 kb resolution, to link a clinical phenotype with a
functional change in copy number, and to detect segmental duplications and associated variations
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in copy number.  These attributes are used successfully in human prenatal testing and can also be
used for rapid genotyping of inter-specific backcross mice.
Comprehensive Genome Structure and Transcriptome Analysis for Mutation Detection
Thomas J. Vasicek, Medtronic, Inc.
Thomas J. Vasicek described applications in genome structure analysis using Massively
Parallel Signal Sequencing (MPSS), which is a method for evaluating gene expression by
counting mRNA molecules in a sample.  Individual mRNAs are identified by sequencing 17-20
nucleotides at a unique site in each mRNA.  Typically, two million molecules are analyzed from
a single sample.  This technology can be used for comprehensive genome-wide analyses of the
transcriptome.
MPSS has traditionally been used for comprehensive, quantitative gene expression
profiling.  Because MPSS determines transcript abundance by a transcript counting method, it
measures absolute transcript abundance and is, therefore, more quantitative than technologies
based on hybridization.  MPSS is also capable of detecting low-abundance transcripts (<100
transcripts per million) that are not detectable using microarray technology.  For example, MPSS
analysis of the transcriptome of human monocytes and immature dendritic cells revealed that
~90% of all transcripts in these cells are represented by less than 100 transcripts per million and,
therefore, would not be detected in a typical microarray study.
Vasicek briefly reviewed several new applications for MPSS, some of which could be
used to map chromosome rearrangements and other mutational events.  These applications
include comprehensive analyses of protein binding sites, DNase I hypersensitivity, DNA
methylation, chromosome breakpoints, and SNPs.  Vasicek emphasized that the MPSS
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methodology is well established, accurate, and reliable; however, for many specific applications
of MPSS, the method of sample preparation requires development and improvement.
MPSS was adapted to carry out BAC end-sequencing for mapping large-scale
polymorphisms.  This version of the assay uses the same principle as end-sequence profiling
(ESP):  a short stretch of DNA sequence is determined at both ends of all clones in a BAC
library of the target genome.  BAC insert lengths are estimated, and the sequence tags are
mapped against the normal genomic sequence.  This permits identification of all amplifications,
rearrangements, insertions, and deletions.  Vasicek also described a modified ESP approach in
which genomic restriction fragments are sequenced directly, and the BAC cloning step is
omitted.  These sequences can be used to identify novel SNPs.  The estimated false-positive
frequency for SNPs identified twice in these sequences is 6 per million base pairs (bp).
Bioinformatics Tools in Germ-Cell Analyses
Michael Primig, Biozentrum and Swiss Institute of Bioinformatics
Michael Primig described GermOnline, a bioinformatic knowledge base focused on
genes and annotation relevant to mitosis, meiosis, germline development, gametogenesis, and
fertility in yeast and higher eukaryotes (see http://www.germonline.org).  The concept of
GermOnline is unique in that the data and annotation are provided, curated, and updated by
members of the scientific community.  GermOnline was developed at the Biozentrum in Basel,
Switzerland and the Swiss Institute of Bioinformatics.  It has mirror sites in Europe, Asia, and
the US to ensure continuous access worldwide.
GermOnline adopted the mechanism of community-based curation to increase the
number of available curators and, therefore, increase the efficiency of database management.
28
This approach was chosen to solve the problem of the small ratio of curators to data that
threatens to overwhelm the IT/bioinformatics community.  Several mechanisms are employed to
maintain the quality and integrity of the knowledgebase, one of which is oversight by an
international board of qualified scientists.  Another mechanism to maintain database quality is to
enforce use of harmonized language and terms, i.e., Gene Ontology (GO) terms.  Thus, in most
areas of GermOnline, data entry is restricted to GO keywords and terms.
GermOnline is a cross-species integrated knowledge base that provides access to data
curated in other molecule- and species-specific databases.  GermOnline is unique among
integrated databases because it is focused on specific biological components and processes that
play roles in germ-cell biology.  GermOnline also provides access to microarray and image data
relevant to the knowledge base.  Future goals for GermOnline include increasing funding, adding
capacity to curate data on protein-DNA interactions and SNPs, and adding video and other types
of image data.
SESSION 7:  LINGERING PUZZLES IN MUTAGENESIS AND INHERITANCE
Session Chair:  Heinrich V. Malling, National Institute of Environmental Health Sciences
Something Curious about Paternal Age Effects and Other Questions in Germ-Cell
Mutagenesis
James F. Crow, University of Wisconsin, Madison
James F. Crow presented an overview of past and current studies on the effect of paternal
age on human germline mutations—the so-called "paternal age effect."  These studies have
focused on several well-characterized human disease syndromes such as Apert, achondroplasia,
X-linked hemophilia, retinoblastoma and neurofibromatosis.  Clinical observations suggest that,
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for these diseases, the number of affected offspring increases more quickly than predicted with
increasing paternal age.  This association suggests that the germline mutation rate increases with
paternal age but not with maternal age and that the mutation rate is higher in human males than
in females.
Molecular analysis of human or mouse germ cells has confirmed some of these clinical
observations.  Further, three classes of mutations have been identified that contribute
differentially to the paternal age effect:  hotspots, insertions/deletions (indels), and base
substitutions.  When present, as in the genes linked to Apert syndrome and achondroplasia,
hotspot mutations tend to occur in males only, and in some cases they increase dramatically with
paternal age.  However, hotspot mutations are gene- and sequence-specific and are, therefore,
relevant only to paternal age effects in a subset of genes.  Approximately two-thirds of the
documented new mutations in the human genome are base substitutions, with the remaining one-
third of mutational events being mostly small and large indels that show no increase with
paternal age.  Crow argued that base substitutions show a slight paternal bias and a smaller, but
significant, paternal age effect than hotspot mutations.  The total paternal age effect in a specific
gene reflects the relative contributions of base substitutions, indels, and hotspot mutations.
Thus, the magnitude of the paternal age effect should vary significantly from one gene to
another.
Radiation and Germline Mutation at Repeat Sequences:  Are We in the Middle of a
Paradigm Shift?
Bryn A. Bridges, University of Sussex
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Bryn A. Bridges described several hypotheses that have been proposed to explain the
estimated 10-fold excess of childhood cancer that occurred among inhabitants of Seascale, UK
between 1950 and 1990.  Seascale is near the Sellafield nuclear power plant, and inhabitants of
Seascale are known to have been exposed to substantial doses of radiation, in some cases
exceeding 100 mSv.  Although initial studies correlated paternal preconception dose with the
number of affected children, this observation has not been reproduced in studies of other groups
of fathers with similar occupational exposures to ionizing radiation.  In addition, it was
concluded that the radiation dose received by Seascale residents and other individuals living
close to nuclear power plants could not alone produce enough mutations to account for the
excess cancer cases in Seascale.
Subsequent analyses of Seascale data have proposed that two additional factors may have
played a role in increasing human cancer rates in the exposed population.  The first factor is
population mixing, as a surrogate for an infectious agent that increases susceptibility to radiation-
induced mutation.  The second factor is a possible epigenetic factor that could amplify the
mutagenicity of a given radiation dose and cause non-targeted mutations distal from sites of
radiation-induced DNA damage, possibly at unstable repeat sequences.
Bridges indicated that no viable explanation for the excess cancer in Seascale has yet
been established.  Bridges also indicated that other studies of the offspring of exposed human
populations remain inconclusive regarding the possible mutagenic effects of radiation exposure.
However, Bridges pointed out that these studies might not have been sufficiently comprehensive
because they did not evaluate subtle birth defects that manifest later in childhood.
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Tandem Repeat DNA Germ-Cell Mutagenesis in Chernobyl, Japanese, and Animal Studies
Yuri E. Dubrova, University of Leicester
Yuri E. Dubrova described studies of the mutation rate in tandem repeat DNA sequences
in exposed human populations.  The human genome has three types of repeated DNA sequences:
minisatellites, microsatellites and extended simple tandem repeats (ESTRs).  The spontaneous
mutation rate at microsatellite and ESTR loci is several orders of magnitude higher than in the
rest of the human genome, and these types of loci account for up to 15% of all gamete genomes.
Minisatellites appear to have a high mutation rate in both human somatic cells and germ cells, so
they may be ideal for studying induced mutations in the human germline.  Most mutations in
ESTRs are gains or losses of repeats, suggesting that they arise via replication slippage.
Importantly, because of the high mutation rate in ESTRs and minisatellite sequences, fewer
samples are needed to detect exposure-induced mutations in these sequences than in single-copy
genes.  Thus, Dubrova estimated that minimum sample sizes of 240, 2,400 or 240,000
individuals are sufficient to measure induced mutations in human minisatellites or mouse ESTR,
microsatellite, and single-copy genes, respectively.
Initial studies compared the radiation dose-response curve for ESTRs with that of the
specific-locus test in mice.  The linear range of effect was lower for ESTRs, but both data sets
appear to fall on the same dose-response curve, suggesting that ESTR sequences are more
sensitive to X-rays than single-copy genes, but that they both reflect the same biological
response to radiation-induced DNA lesions.  Similar results were obtained for ENU mutagenesis
in mice.  These data suggest that ESTR loci can be used to monitor the mutagenic response to
low-dose exposures using a relatively small number of exposed animals or humans.
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A small number of studies have analyzed mutations in human repeat sequences in
exposed human populations.  Dubrova summarized the results of four of these studies:  (1) 6
repeat loci in 64 children of Hiroshima bomb survivors, (2) 8 repeat loci in 367 children of
Chernobyl survivors, (3) 8 repeat loci in 232 children of residents near the Semipalatinsk nuclear
test site, and (4) 8 repeat loci in 338 offspring of Chernobyl cleanup workers.  Studies 1 and 4
were negative, and studies 2 and 3 showed significant correlations between paternal but not
maternal exposure and mutation rate.  Dubrova proposed three factors to explain the negative
result in atomic bomb survivors:  first, this population generally received smaller radiation doses
than the other exposed populations; second, the number of individuals studied may have been too
small for detecting significant differences; and third, this study did not distinguish subjects
according to paternal or maternal exposure.  Dubrova indicated that the negative result in study 4
was expected because Chernobyl cleanup workers were exposed to fractionated radiation doses.
In closing, Dubrova indicated that more studies are needed to determine the effect of
chemical or radiation exposure on repeat-sequence variability in the human germline.  The initial
results reported here are encouraging, suggesting that epidemiological studies with relatively
small exposed populations have sufficient power to detect induced mutations in repeat sequences
in the human germline.  Additional studies will be needed to determine the relationship between
the mutation rate in repeat sequences in the human genome and the rate of functional mutations
in single-copy human genes.  Dubrova's laboratory currently focuses on the comparative effects
of radiation on minisatellite mutation rates in a number of exposed cohorts.
Heritable Mitochondrial Mutagenesis
Eric A. Shoubridge, McGill University
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Eric A. Shoubridge discussed mouse and human mitochondrial genetics and the impact of
mutations in the mitochondrial genome on fertility and disease.  The mitochondrial genome is
small, with 13 protein-coding genes, most of which play essential roles in oxidative
phosphorylation.  In most cases, mtDNA is homoplasmic, but in some cases, more than one
mtDNA variant co-exists in a single organelle (heteroplasmy).  The replication of mtDNA is not
under cell cycle control, but the number of copies of mtDNA per mitochondrion is regulated and
maintained at 2-10.  mtDNA is transmitted to embryos exclusively from the cytoplasm of the
maternal germline.  Thus, its inheritance is non-Mendelian.  Mitochondria have the capacity to
repair DNA lesions, but the mutation rate in mtDNA is ~10-fold higher than in genomic DNA.  
Many human diseases are associated with mtDNA variants that arise through
spontaneous or induced mutations in the mtDNA in somatic or germ cells.  The variant mtDNAs
can be present as a variable fraction of the total mtDNA, and they cause multiple complex
phenotypes that are poorly understood.
Shoubridge used a mouse model to analyze the segregation of mtDNA variants during
oocyte development and early embryogenesis.  Most mice within a strain are homoplasmic for a
single mtDNA variant, but the mitochondrial genome in NZB mice differs at ~100 sites from the
mtDNA of BALB/C.  Shoubridge generated cytoplasmic hybrid mouse embryos carrying NZB
and BALB/C mtDNA and then bred a resulting founder heteroplasmic female, in which ~4% of
the total mtDNA was the NZB variant, to a male from a different strain.  The pups from this
female carried from 0 to 25% NZB mtDNA, but the mean NZB mtDNA frequency was equal to
the frequency in the mother.  This finding suggests that mtDNA rapidly segregates by a
stochastic process that does not ensure equal distribution of variant mtDNA genomes.  Through
detailed analysis of the segregation of mtDNA variants at different stages in oogenesis,
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Shoubridge concluded that all mtDNA segregation occurs prior to formation of the primary
oocyte.  He also observed that the number of mtDNA molecules per primordial germ cell is low,
and he proposed that this creates a bottleneck for mtDNA distribution during female
gametogenesis.  There also appeared to be no selection against mutant mitochondrial genomes;
however, these defective genomes do not appear to reduce female fertility.
SESSION 8:  RESEARCH CHALLENGES IN MUTAGENESIS AND INHERITANCE
Session Chair:  Steve S. Sommer, City of Hope Medical Center
Germ-Cell Methylation in Mutagenesis
Jaquetta M. Trasler, Montreal Children’s Hospital Research Institute
Jaquetta M. Trasler described mechanisms for establishing and maintaining patterns of
DNA methylation in mammalian genomes.  DNA methylation is one of the best-characterized
epigenetic mechanisms for modulating gene function.  DNA methylation is required for X-
inactivation and gene silencing, and recent studies show that DNA methylation is critical for
gene imprinting.  Defective imprinting is associated with human diseases such as Prader-Willi,
Angelman, and Beckwith-Wiedemann syndromes, and aberrant DNA methylation has also been
linked to some human cancers.  Some studies also suggest that aberrant DNA methylation may
occur in human embryos produced by ART, and if confirmed, this could have implications for
the susceptibility to imprinting-associated diseases in children conceived by ART.
The mechanisms by which DNA methylation patterns are inherited are complex.  Most
methylation is maintenance methylation, which occurs post-replicatively on hemi-methylated
DNA.  However, the genome is "reprogrammed" twice, once during gametogenesis and once
during embryogenesis.  Reprogramming occurs according to different time lines in male and
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female gametes.  Male progenitor germ cells begin to be methylated before birth and continue to
be methylated at some sites after birth.  In contrast, female germ cells are reprogrammed
primarily after birth.  In the somatic tissue of the mouse embryo, reprogramming takes place
during days 15-17 of gestation.  However, the exact timing of methylation in embryonic cells
varies in a gene-specific manner.
Several murine DNA methyltransferases (DNMT) that play roles in de novo and
maintenance DNA methylation have been cloned and characterized.  DNMT1 is involved in
maintenance methylation of hemi-methylated DNA and DNMTs 3A and 3B are involved in de
novo methylation during DNA reprogramming.  Knockout mice lacking DNMT1 show a lack of
imprinting at the 8-cell embryo stage, consistent with its role in maintenance methylation.
Knockout mice for DNMT3A show impaired germ-cell development in both males and females,
with complete infertility in females.  This result confirms the role of DNMT3A in de novo
methylation in the mouse germline.  DNMT3B knockouts have no defect in gametogenesis, and
DNMT3L has no detectable methyl transferase activity; nevertheless, deficiency in this enzyme
interferes with maternal imprinting and causes male sterility.  The mechanism of this effect is not
understood.
Trasler pointed out that little is known about how environmental agents affect DNA
methylation in somatic or germ cells.  However, molecular approaches have been developed for
detailed analysis of DNA methylation in specific genes or on a genome-wide basis.  These
methods, including bisulfite sequencing, restriction landmark genome scanning, and methylation
profiling, can be used to begin to address this question and to study the consequences of defects
in DNA methylation in animal model systems.
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Epigenetic Trans-generational Actions of Endocrine Disruptors on the Male Germline and
Fertility
Michael K. Skinner, Washington State University
Michael K. Skinner described environmentally induced trans-generational changes in
methylation in male germ cells in the rat.  Skinner discovered this phenomenon while testing
whether the endocrine disruptor, vinclozolin, had adverse effects on testis development and
germ-cell differentiation in male rat embryos.  When rats were exposed to vinclozolin in utero
from embryonic day (ED) 7 to ED15, male pups demonstrated decreased seminiferous cord
formation and increased rates of apoptosis in spermatogonial cells.  Decreases in sperm motility
and sperm number were also noted in male offspring only when embryos were exposed during
ED13-ED15, which is the most critical period for testis development in the rat embryo.
Approximately 10-15% of the exposed male pups were completely infertile.  When a number of
the in utero exposed, sperm-defective but fertile males were inadvertently mated, Skinner
discovered that the exposure-induced symptoms were transmitted to the offspring of the affected
males.  His laboratory demonstrated that these exposed animals acquired a heritable phenotype
that was transmitted through at least four generations.
Skinner tested the hypothesis that vinclozolin exposure had disrupted methylation
patterns in the male germline of exposed rats.  Characterization of methylation patterns in the
genomic DNA of affected males identified 25 known genes and 21 unknown genes whose
methylation patterns differed in exposed and unexposed animals.  Similar results were observed
when gene-specific DNA methylation was examined in male germ cells.  The affected genes
included STAT-like transcription factors.  These results led Skinner to propose that transient
exposure to vinclozolin during stages ED13 to ED15 caused a permanent epigenetic
37
reprogramming of specific genes in male germ cells that led to an exposure-induced trans-
generational phenotype, including adverse effects on male fertility.  One possible mechanism for
the genetic reprogramming might be vinclozolin-induced changes in transcription during stages
ED13-ED15.
Subsequent characterization of affected males revealed significant adverse effects in
older animals.  The late phenotype included male breast tumors, premature aging, prostate
degeneration, increased prevalence of severe and/or complete male infertility, and a pre-
eclampsia-like phenotype in late-stage pregnancy in females.  This study suggests that
environmental agents might cause trans-generational effects by an epigenetic mechanism.  It also
confirms the existence of gender-specific windows of susceptibility in which germ cells and/or
germline progenitor cells are susceptible to environmentally induced adverse effects.
Trans-generational Effects of Low-Dose Mutagenesis
Diana Anderson, University of Bradford
Diana Anderson reviewed the evidence that low-dose environmental exposures to
radiation and chemicals can induce adverse heritable effects in humans and animals.  The
evidence for such effects in humans is limited and includes observations of increased cancer
prevalence in the vicinity of nuclear power plants or among children of male smokers.
Numerous studies of exposed humans have failed to provide evidence of adverse effects,
including a study of the rate of birth defects among the offspring of ~18,000 cancer survivors.
Anderson emphasized the value of rodent models for detecting the effects of low- or
high-dose exposure by monitoring adverse birth outcome or induction of chromosomal
aberrations.  Substantial data are available to support low-dose exposure effects on heritable
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mutations in rodents.  Nevertheless, this association is more ambiguous for low-dose than for
high-dose exposures, which cause abundant birth defects in rodents.
  Anderson reviewed studies of adverse effects in animals and humans exposed to
environmental chemicals, including cyclophosphamide, 1,3-butadiene, and urethane.  Using an
animal model of male-mediated teratogenicity, Anderson showed that the offspring of male
rodents acutely exposed to cyclophosphamide had numerous birth defects as well as
chromosome abnormalities and increased tumor incidences.  In addition, she discussed the
results of several low-dose exposure studies.  A chronic low dose of 1,3-butadiene increased the
frequency of adverse pregnancy outcomes.  Recent epidemiological data support the possibility
that occupational exposure to 1,3-butadiene induces adverse reproductive effects in humans.  In
contrast, low-dose urethane exposures increased the rate of liver tumors in exposed males but did
not cause birth defects.
In closing, Anderson emphasized the potential usefulness of animal models in identifying
chemicals that may be hazardous to germ cells and in establishing the affected germ-cell stages
and the exposure doses of greatest concern.  She further recommended additional use of these
models for characterization of potential adverse health impacts resulting from environmental
exposures to male germ cells in humans.
SESSION 9:  CHALLENGES IN LINKING HUMAN EXPOSURE TO INCREASED
MUTATIONS AND HEALTH CONSEQUENCES IN OFFSPRING
Session Chair:  Mort Mendelsohn, Lawrence Livermore National Laboratory
Inherited DNA Repair Defects and Human Disease
Philip C. Hanawalt, Stanford University
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Philip C. Hanawalt outlined the multiple cellular pathways for repairing damaged DNA,
and he reviewed a number of human hereditary diseases resulting from defects in DNA damage
processing.  The genome is continuously assaulted by many exogenous and endogenous agents,
e.g., reactive oxygen species, which induce lethal or mutagenic DNA lesions.  The recognition of
lesions, or their inhibitory effects on the processes of replication or transcription, triggers cellular
responses that may arrest the cell cycle, induce apoptosis, and/or up-regulate expression of DNA
repair enzymes to repair DNA damage.  There are three DNA excision repair pathways:
nucleotide excision repair (NER), base excision repair (BER), and mismatch repair (MMR)
targeted to different types of DNA damage, but with a considerable degree of overlap in
substrate specificity.  Additionally, recombinational mechanisms are utilized to deal with double-
strand breaks, interstrand crosslinks, closely spaced lesions on the respective DNA strands, and
some types of replication fork arrest.  Mutations in genes encoding DNA repair proteins cause
phenotypic effects on growth, cell-cycle progression, susceptibility to DNA damage, meiosis,
and other biological processes in model systems, such as yeast.  Although NER and MMR may
result in genomic instability, BER appears to be essential in mammalian species because it has
not been possible to isolate viable BER-deficient mutants in mice.
NER is a complex process involving the concerted action of ~30 proteins which
recognize the lesion, remove a short segment of the damaged strand, replace it using the
complementary DNA strand as template for repair replication, and seal the “repair patch” by
ligation to the contiguous parental strand.  NER targets primarily bulky helix-distorting lesions,
and there are two NER repair sub-pathways:  global-genome repair (GG-NER) and targeted
repair (TC-NER or TCR).  Human hereditary defects in NER cause several distinct diseases,
including xeroderma pigmentosum (XP), Cockayne syndrome (CS), UV-sensitive syndrome
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(UVSS), and trichothiodystrophy (TTD).  These syndromes are all characterized by marked sun
sensitivity and, usually, a striking clinical and genetic heterogeneity with pleiotropic features,
including developmental and neurological abnormalities and variable signs of premature aging.
XP patients, defective in GG-NER, have a 1000-fold increase in skin cancer predisposition,
whereas CS, UVSS, and TTD patients, defective in TCR, do not have increased cancer risks.  In
the case of UVSS, sensitivity to sunlight is the only clinical feature, whereas in CS the hallmarks
are the neurological and developmental problems. The basis for the difference is unclear because
both diseases are characterized by the TCR defect.  A current working hypothesis is that UVSS
patients retain the ability to carry out some TCR, whereas patients with CS are totally deficient
in TCR.
Hanawalt noted that there are important differences in the efficiency of GG-NER in
rodent cells compared to human cells—rodent cells lack expression of the XPE gene, which
codes for a component of a DNA damage-binding activity.  The reduced global repair efficiency
in rodents may account for the higher rates of mutagenesis and carcinogenesis compared to
humans following exposure to carcinogens such as UV.  This difference in GG-NER capability
in somatic cells establishes that rodents are imperfect surrogates for humans in genetic
toxicology studies.
Hanawalt briefly described studies by others on NER in murine spermatogonial cells.
Overall, the results suggested cell-type specific NER activity.  Although all cell types were
proficient in TCR, A and B type spermatogonia displayed low-to-moderate ability to repair the
test lesion (UV-induced cyclobutane pyrimidine dimers) on both strands of expressed genes.
GG-NER was more efficient in mouse primary keratinocytes than in the spermatogenic cell
types.  Also, GG-NER activity appeared to decrease with age in postmeiotic cells.
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Other cancer-prone human diseases caused by DNA repair defects include ataxia
telangiectasia, Bloom syndrome, and Werner syndrome.  The defects in these human diseases
lead to aberrant DNA damage signaling and/or improper processing of DNA repair
intermediates.  Bloom syndrome and Werner syndrome patients have defects in multifunctional
RecQ family proteins with DNA helicase activity.  Finally, it was noted that defects in human
mismatch repair genes are linked to a hereditary form of colon cancer and to sporadic colon and
endometrial cancer.  Variation in DNA repair capacity may alter the susceptibility of individual
parents to germ-cell mutagenesis after exposure to environmental mutagens.
Clinical and Economic Aspects of Mutation Detection
Robert P. Erickson, University of Arizona Health Science Center
Robert P. Erickson reviewed current issues in implementing molecular genetic assays in
clinical medicine.  High-throughput molecular genetics has changed the face of medical research
dramatically, but it has perhaps had less of an impact on clinical medicine than one might expect.
For example, it is technically feasible to use gene-chip methodology to screen for any of 1000
possible mutations that cause cystic fibrosis.  However, the logistics of gene-chip development
are difficult, and the cost per chip is high because of the large number of patents on DNA
sequences and DNA-based technologies.  Furthermore, there appears to be significant resistance
among clinical professionals to increased use of molecular diagnostics.  Erickson predicted that
gene-chip technology will eventually emerge and be widely used to rapidly screen for genetic
defects, but this implementation will occur only after many existing DNA patents have expired
and chip costs drop significantly.
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Another factor that limits use of molecular diagnostics in clinical settings is the fact that
insurance companies are reluctant to pay for these tests.  This attitude may change as therapeutic
intervention options increase because insurance companies prefer to pay for tests whose results
will influence the selection of therapy and, thereby, possibly improve prognosis.  Erickson
encouraged wider future attention to developing tests for genetic mosaicism in somatic tissue.
He felt that this advance could have significant impact because genetic mosaicism may currently
go undetected as the cause of a significant fraction of human disease.
Feasibility of Epidemiologic Studies
John D. Boice, Vanderbilt University Medical Center
John D. Boice reviewed epidemiological studies of heritable disease phenotypes in
exposed human populations, including atomic bomb survivors, radiation workers, individuals
exposed to diagnostic X-rays, individuals exposed to high levels of environmental radiation, and
cancer survivors.  These studies looked at many health indicators, e.g., adverse pregnancy
outcome, sex ratio, childhood cancer, death of offspring, cytogenetic abnormalities, and
minisatellite mutation rate.  Approximately 80,000 individual offspring were included in the
study of atomic bomb survivors alone. On the whole, the results were negative. The 2001 United
Nations UNSCEAR panel concluded that "no radiation-induced genetic diseases have so far been
demonstrated in humans…[therefore] estimates of risk have to be based on mouse experiments."
Boice argued that doses below 0.2 Gy (20 rad) are unlikely to double the risk of an adverse
pregnancy outcome, and UNSCEAR estimated genetic risk as ~0.2% per Gy and the doubling
dose ~1 Gy (100 rad).
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In contrast, there is evidence of radiation-induced chromosome aberrations in exposed
persons.  Although offspring of cancer survivor cohorts do not show increased cancer rates,
cancer survivors themselves show strong evidence of exposure-induced secondary cancers.  One
explanation for these results is that epidemiological studies of exposed human populations to
date may have lacked sufficient power and dose range or failed to measure appropriate
outcomes.  In addition, affected offspring may elude detection because they may be eliminated
by such natural biological processes as early miscarriage.
Epidemiologists are continuing to look for evidence of effects on the rate of heritable
genetic disease in offspring of human cancer survivors.  A large-scale international collaboration
is currently conducting a demonstration project focused primarily on adverse pregnancy
outcomes.  Analysis of chromosome abnormalities will be carried out in offspring, and selected
trios will be studied using molecular methods, including minisatellite characterization.  Variation
in radiation response will be examined using in vitro cytogenetic assays in conjunction with gene
profiling.  Efforts have been made to calculate precisely the gonadal dose received by each
exposed individual.  Administered chemotherapy will also be quantified.  Results of this study
may provide definitive answers to questions about the integrity of the germline in exposed
human populations.
Risk Assessment
K.  Sankaranarayanan, Leiden University Medical Centre
K. Sankaranarayanan discussed several novel concepts that could be used to develop a
new or modified paradigm for assessing human genetic risk from exposure to ionizing radiation.
He pointed out that the existing paradigm is based on the assumption that adverse effects of
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radiation will be manifested in progeny of exposed individuals as genetic diseases similarly
distributed to those that occur naturally in the population.  Because human data are extremely
limited, risk is generally estimated using three components: the doubling dose for radiation-
induced germ-cell mutations in mice, the background rate of "spontaneous" genetic disease in
humans, and population genetics theory.  Recent estimates suggest that the genetic risk
associated with chronic, low-dose irradiation is ~4,000 affected cases per million births per Gy.
This rate represents 0.4 to 0.6% of the baseline frequency of affected births (738,000 cases per
million births).  The baseline estimate includes chronic multi-factorial diseases in the population
(650,000 per million; mostly of adult onset); congenital abnormalities (60,000 per million);
Mendelian diseases (24,000 per million); and chromosomal diseases (4,000 per million).
Therefore, among diseases recognized at birth, chronic low-dose radiation may account for 0.5%,
which is nearly equivalent to the incidence of chromosomal abnormalities recognized at birth.
 Recent studies in experimental systems have demonstrated that most radiation-induced
mutations are large DNA deletions encompassing multiple genes.  Thus, it is reasonable to
assume that many radiation-induced deletions cannot be recovered and characterized in offspring
because they are lethal during early stages of development.  Further, large DNA deletions that
are viable are likely to cause developmental abnormalities in multiple organs/systems.
Sankaranarayanan presented an analysis that can be used to predict the rate at which non-
lethal radiation-induced multigene deletions should occur in the mouse or human genome.  This
analysis is based on molecular understanding of the mechanisms by which such deletions occur
and the distribution of non-segmental duplications in the mouse and human genomes.  It is
thought that a large fraction of the biological impact of radiation on the cellular level is due to
misrepair or lack of repair of radiation-induced double-strand breaks (DSBs).  DSBs are repaired
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by three major pathways in mammalian cells:  non-allelic homologous recombination (NAHR),
homologous recombination (HR), and non-homologous end-joining (NHEJ).  Sankaranarayanan
proposed that germ cells favor NAHR-dependent DSB repair and that low-copy repeats (LCRs)
are hotspots for radiation-induced deletions.  Thus, Sankaranarayanan argued that detailed
analysis of genome architecture should allow one to predict the sites where a multigene deletion
mediated by a pair of LCRs will not be lethal.  It may be possible to test these ideas in
experimental studies in mice and through molecular analysis of human fetuses or neonates.
Additional analysis of the distribution of LCRs in the human and mouse genome is also needed.
Sankaranarayanan suggested that these data and available bioinformatics tools could be used to
predict the expected rates of NAHR-mediated radiation-induced deletions that can be recovered
in human live births.
OPEN DISCUSSION SESSION 1
Integrating New Technologies in Germ-Cell Mutagenesis
Discussion leaders:  Joe Gray, Lawrence Berkeley National Laboratory; Sally Perrault-
Darney; US Environmental Protection Agency; and Colin H. Collins, University of
California, San Francisco
The goal of this session was to explore how current molecular technologies could be
applied to answer key questions in the field of germ-cell mutagenesis.  Gray presented a matrix
of technologies for assessing DNA and genomic defects and related them to the biological
endpoints that could potentially be measured or analyzed with those technologies (Table 1).  The
most promising technologies included PCR-based sequencing, PCR-based conformation
analysis, sequencing by hybridization, end-sequence profiling (ESP), primer extension, FISH,
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CGH, optical mapping, genome subtraction, expression arrays, Serial Analysis Gene Expression
(SAGE, both RNA and DNA), Chromatin Immuno Precipitation (ChIP) assays, protein lysate
arrays, 1- & 2-D gel electrophoresis, mass spectrometry, and computational biology.  ESP is a
relatively new technology that can clone and map many kinds of chromosomal defects, e.g,
deletions, insertions, translocations, inversions, copy number changes, in a single step.  The
resolution of ESP is relatively high (10 kb), and this powerful technology could be useful for
identifying and characterizing environmentally induced germ-cell mutations.  The two main
disadvantages of ESP are its high cost and the expertise required for BAC library construction.
The biological parameters that might be analyzed by ESP included genome-wide mutation rate,
chromosome aberrations, multigenic disorders, locus-specific mutation rate, DNA methylation,
genetic mapping, gene function, and gene expression profiling.
The ensuing discussion explored this matrix in detail, and several important points were
raised during the discussion:
• There was a consensus in support of a collaborative project to use these new genomic
technologies to measure induced mutation rates in germ cells in a human population with a
well-characterized germ-cell exposure.  A complementary mouse model system would be
essential because of the relative ease of manipulating experimental conditions in mice, in
contrast to the relative difficulty of determining exposure and controlling variables in human
subjects, and the relative difficulty of obtaining human samples.  Although no specific
technology was identified, it was suggested that different technologies could be evaluated by
expert laboratories using a central source of samples, i.e, a bio-bank.  Discussants
recommended that a single mutagenic agent be selected as a focus of this project.  Because of
the extensive knowledge base in animals and humans, radiation exposure was suggested as
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the focus for the new project.  Offspring of childhood cancer survivors were also suggested
as an ideal study population.
• The average spontaneous base-pair mutation rate in the human genome is approximately 1 X
10-7 per cell per generation.  Thus, technologies for detecting induced germ-cell mutations
must be able to measure changes at a rate of 1 X 10-7 bp, with error rates below that level.
• Potential germ-cell mutagens should be assessed for ability to act through both genetic and
epigenetic mechanisms.
• Molecular techniques should identify various types of mutations, including single-base
substitutions, chromosome aberrations, and aneuploidy.  Alterations induced in noncoding
regions would be more difficult to assess.
• There are advantages to measuring mutation rates directly in sperm DNA, and methods are
already available for the analysis of human and animal sperm.  Results from experiments
with sperm cannot be extrapolated to oocytes, and separate methods would be needed to
study effects of environmental exposures on oocytes.
• Meeting participants urged establishment of a bio-bank as a resource for the germ-cell
mutagenesis community.  Additional and improved database resources were also
recommended.
• Meeting participants discussed the relative advantages and limitations of the use of
transgenic mouse models in germ-cell mutagenesis and assessment of heritable risks.
OPEN DISCUSSION SESSION 2
Research Recommendations for Assessing Mutations in the Post-Genome Era
Leader:  John J. Mulvihill, University of Oklahoma Health Sciences Center
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This session was devoted to developing recommendations and proposals for future
activities in germ-cell mutagenesis research.  In his opening comments, Victor A. McKusick
(Johns Hopkins University) provided some historical perspective, relating the current task of
understanding germ-cell mutagenesis to his personal experience working on the Human Genome
Project and the Online Mendelian Inheritance of Man database.  These projects, which generated
a draft human genome sequence and a catalogue of human genetic diseases and associated
mutations, respectively, generated tools that will be useful in understanding the mutability of the
human genome.  Extensive discussions focused on funding initiatives, resources, and
technologies of value to future research efforts, as well as experimental designs for studying
human germ-cell mutagenesis.
John J. Mulvihill noted that many of these recommendations for germ-cell mutagenesis
research were first proposed at the 1984 meeting in Alta, Utah that presaged the Human Genome
Project (listed below) and were still relevant today.
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Mulvihill pointed out that the new genomic technologies introduced at this meeting provide new
avenues for detecting and characterizing induced germ-cell mutations in a manner not previously
possible.
Richard P. Woychik (The Jackson Laboratory) discussed the need to understand cell-
type-, species- and exposure-dependent differences in mutagenic outcome.  Woychik argued that
this complexity dictates an integration of different approaches and strategies for understanding
and analyzing human germ-cell mutagenesis.  Woychik also emphasized the importance of
distinguishing the proposed program from other genome-based programs with implications for
human mutagenesis.  Woychik proposed generating a white paper on the mutability of the human
germline, whose raison d'etre would be to increase awareness of issues and concerns in this field.
Several specific experimental approaches were proposed that could increase our
understanding of human germ-cell mutagenesis.  Jack A. Taylor (NIEHS) proposed that 100
offspring of childhood cancer survivors and their parents, i.e., 100 trios be used as a target
population for SNP analysis.  He also suggested that ~100 genes would be resequenced in each
of the offspring, and all SNPs would be recorded and analyzed.  If putative novel SNPs were
found, then the parental (somatic) genomes would be re-sequenced to determine if the
polymorphic sites were rare variants, pre-existing in the parental DNA, or if some of them could
be attributed to new mutations in parental germ cells.
Harvey W. Mohrenheiser (Oregon Health Sciences University) also strongly advocated
using childhood cancer survivors as a cohort for extensive study of genetic changes and heritable
genetic disease.  By analyzing this exposed population, he argued, the human genetic risk from
exposure to mutagens becomes a tangible, real-world problem and not a theoretical question
lacking public health relevance.  Mulvihill emphasized that one of the benefits of studying
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childhood cancer survivors and their offspring is that the levels and conditions of exposure are
precisely known from patient medical records.  This information greatly increases the potential
value of analyzing such an exposed population relative to most other exposed human
populations.
Bryn A. Bridges (University of Sussex) suggested that analysis of minisatellite sequences
in exposed human populations, including childhood cancer survivors, is a promising
experimental strategy because there is already evidence that increased mutation rate in
minisatellites is associated with human exposure to ionizing radiation.  Thus, a system for
rapidly and efficiently detecting minisatellite mutations should be developed, automated, and
applied to other exposed human populations.  The link between exposure and hereditary disease
would then be explored by correlating minisatellite mutations and functional coding-sequence
mutations in the same exposed individuals.  The objective in this experimental strategy is to
ascertain whether the minisatellite system is a valid indicator for human germ-cell mutagenesis.
Bridges emphasized that studies will be needed across several dose ranges and conditions, from
acute high-dose exposure to chronic low-dose exposure.
George R. Hoffman (Holy Cross College) suggested that the study of germ-cell
mutagenesis needs to remain broad-based, encompassing such diverse effects as point mutations,
chromosome aberrations, aneuploidy, complex traits, epigenetic effects, and minisatellite
variation.  A multifaceted strategy is needed on the molecular level, and a similarly broad
approach is needed to assess phenotypic effects of germ-cell mutagens.
The following points were also raised in this discussion session:
• Care should be taken to differentiate hereditary effects from somatic-cell variation and/or
mosaicism.
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• The Complex Trait Consortium (www.complextrait.org) is generating 1000 recombinant
inbred mouse strains from 8 parental inbred strains.  This might be a useful resource for
studies of germ-cell mutagenesis in the mouse.
• Animal models will continue to be essential for developing a mechanistic understanding of
germ-cell mutagenesis.  Thus, it will continue to be important to understand the differences
and similarities in the effects of mutagen exposure on mouse and human germ cells.
• A comprehensive understanding of human germ-cell biology will be essential for
understanding the mutability of human germ cells.  This endeavor should include
understanding of germ cell stage-dependent or sex-specific variation in the genetic risk
associated with environmental exposure.
WORSKHOP SUMMARY AND RECOMMENDATIONS
Birth defects, genetic diseases, and chromosomal abnormality syndromes occur in
approximately 5% of all live births, and affected children suffer from a broad range of lifelong
health consequences.  Many of these consequences are associated with high familial and societal
costs.  This workshop addressed the challenges to understanding the causes of these seemingly
“random” genomic defects and to identifying the relevant risk factors so that they might be
mitigated.  Because affected children often carry de novo mutations, i.e., those not present in
either somatic cells of either parent, these genomic changes are likely to have arisen in germ
cells of one parent or during early development.  In stark contrast to cancer, where the majority
of causes are associated with environmental exposures and where differences in genetic
susceptibility can dramatically alter an individual’s risks, there is no comparable understanding
of the causes or individual susceptibilities for human birth defects and heritable diseases.
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Indeed, the status of the research is such that there is still no direct scientific evidence for the
existence of a transmissible, environmentally induced, human germ-cell mutation, although the
indirect evidence from human and animal studies is increasingly strong.  Recent major advances
in genome analysis technologies have provided the tools to obtain such evidence, and these
rapidly developing technologies were a major motivation for holding this workshop.
Research into the detection of human germ-cell mutagens and the prevention of
associated developmental defects and heritable genetic diseases faces three major challenges:  (1)
understanding the special biology of male and female gametogenesis as it pertains to mutation
susceptibility and risk of damage transmission; (2) developing effective technologies for
detecting the broad spectrum of mutations known or predicted to be associated with germ-cell
mutagens, developmental defects, and heritable diseases; and (3) initiating research strategies to
investigate induction of germ-cell mutations in exposed human populations.
Male and female germ cells each have a unique biology that influences their
susceptibilities to germ-cell mutagens, and these susceptibilities change dramatically throughout
the course of germ-cell development, maturation, and fertilization.  In animal studies, the types
of mutations seen in offspring depend strongly on the agent and the exact timing of exposure
during germ-cell development.  Similar specificities have been noted in sperm studies with
patients receiving mutagenic chemotherapy.  This critical relationship between agent, dose,
timing, and outcome was considered by the workshop participants to be of paramount
importance for identifying appropriate exposed human populations for germ-cell mutagenesis
studies.
The detection of germ-cell mutagens is highly complicated by the broad spectrum of
chromosomal defects and gene mutations known to be associated with birth defects and heritable
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diseases.  Rodent studies have shown that even exposures limited to one germ-cell mutagen often
induce a spectrum of transmissible damage and that mutagens can differ dramatically in the types
of transmissible damage they induce.  Types of transmissible damage include base-pair
alterations, repeat-sequence changes, and a variety of chromosomal abnormalities, e.g.,
duplications, deletions, rearrangements, and aneuploidies.  In addition, recent animal studies
have shown that altered imprinting patterns, not associated with mutations, can lead to heritable
multigenerational defects.  Therefore, workshop attendees emphasized that approaches to
studying germ-cell mutagenesis in humans must remain broad-based, and investigations should
include the full spectrum of detectable genetic and chromosomal endpoints.
This workshop highlighted the impressive technological advances for investigating DNA
sequence and chromosomal alterations that were developed in conjunction with the Human
Genome Project (Table 1).  These technological innovations include advances in high-throughput
DNA sequencing; detection of chromosomal duplications, amplifications, and deletions; gene-
transcript profiling; and proteomics.  The advantages and limitations of these technologies were
discussed in detail by the workshop participants.  For example, the cost of high-throughput DNA
sequencing was noted to have dropped dramatically (now ~US$1/1000 bp), making it
particularly promising for investigations of genome-wide DNA sequence alterations in the
children of parents with induced germ-cell mutations.
One of the major issues facing the field of germ-cell mutagenesis is to identify candidate
germ-cell mutagens for intensive human study, and several strategies for identifying these were
discussed during the workshop.  These included animal breeding screens, animal and human
gamete analyses (especially defects in sperm genomes), and epidemiological pilot data.
Consistent with the special biology of germ cells, it was emphasized that data from somatic-cell
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mutagenicity studies cannot be extrapolated directly to germ-cell risk and that determination of
human germ-cell risk requires direct studies of exposed germ cells.
There was consensus on the importance of mounting coordinated animal and human
germ-cell mutagenesis studies to explore the impact of important societal exposures, such as the
effects of advancing age or exposure to cancer therapy in childhood cancer survivors.  It was
recommended that such studies be initiated as soon as possible, both in humans and in parallel
animal models, using some of the genomic tools currently available.  Cancer survivors represent
a unique cohort with well-defined exposures and genetic alterations, including base-pair changes,
chromosomal alterations, repeat-sequence and minisatellite mutations, and gene-expression
profiles.  Other types of genomic alterations can be measured in their offspring, using as
reference both the parent without cancer as well as the parental cancer survivor.  The need to
create a bio-bank of human tissue samples, e.g., from cancer patients and their children, was also
advocated by attendees.  Such a bio-bank is critical to conducting a multi-endpoint,
comprehensive, collaborative assault aimed at detecting exposure-induced heritable alterations in
the human genome.  There was also strong support for using appropriate animal models of
human germ-cell mutagenesis in parallel with studies in humans to provide insights into the
biology and biochemical mechanisms of germ-cell mutagenesis.
In conclusion, based on the wealth of data from animal studies, the following questions
regarding the risks for inducing human germ-cell mutations stand to be addressed by the research
community:
1.  What environmental, occupational, or medical agents increase the risk for germ-cell
mutations through classical, direct mechanisms, i.e., point mutations, chromosomal alterations?
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2.  What environmental, occupational, or medical agents increase the risk for germ-cell
alterations through indirect or epigenetic mechanisms?
3.  For both direct and indirect mechanisms, what is the potential for transmissibility to a zygote
and to a live born child?
4.  To what degree does individual susceptibility affect risk, and can we identify individuals with
increased susceptibility?
5.  What is the differential risk to male germ cells compared with female germ cells for the same
exposure?
 Because of the relatively high incidence of adverse reproductive outcomes and de novo
genetic diseases that characterize the human species, there is a pressing need to identify, define,
and control the environmental factors that contribute to these adverse outcomes and genetic
diseases.  Given the potential magnitude of overall risk resulting from our exposure to the
complex mixture of environmental chemicals, it is essential that human studies and parallel
animal studies be designed and initiated to provide an accurate estimate for risk of transmissible
mutations and to develop approaches to reduce that risk.  The technologies are now available to
allow us to investigate and address this urgent issue, which has an enormous potential public
health impact.
As noted in the Introduction, it has been 80 years since the discovery of the first germ-
cell mutagen.  Unless we initiate immediately the studies proposed here, we may find ourselves
asking the same questions 80 years from now:  Are there any human germ-cell mutagens, what
risks do they pose to future generations, and are some parents at higher risk for germ-cell
mutations than others?
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TABLE I.  Technologies for Assessing DNA and Genomic Defects
Genome analysis
technology
Major utility
Applicable to
single-cell
analyses
Genomic
resolution
PCR-based assays (sequencing
or conformation)a Single-gene assessment, methylation Yes Single base
Sequencing by hybridization Allelotyping, mutation detection Yes Single base
End-Sequence Profiling (DNA
& transcripts)
Structural rearrangements, large- scale
resequencing, genome immortalization
No
Primer extension
Antibody based multi-protein
interrogation Noa Single
protein
FISHb Numerical and structural chromosomal
aberrations
Yes Megabase
CGH Copy number gains and losses, allele
specific, methylation specific
Possibly 10-100Kbp
High throughput LOH LOH mapping, gene localization 100 Kbp
Optical mapping Numerical and structural chromosomal
aberrations
Yes 100 Bp
Genome subtraction
Mapping and cloning of lost or gained
regions Possibly Megabase
Expression arrays
Comprehensive, semi-quantitative
expression, splicing Yes Single exon
SAGE (RNA & DNA)
Comprehensive, quantitative expression,
splicing No Single gene
ChIP
DNA binding proteins, chromatin
structure No Single gene
Protein lysate arrays Antibody based multi-protein
interrogation
Noa
Single
protein
1D & 2D gel electrophoresis Mutant protein detection
Single
protein
Mass spectrometry Qualitative protein composition Single
protein
a~100 cells are needed.
bTechnologies adapted to the analyses of genomic defects in human and animal sperm.
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